95 related articles for article (PubMed ID: 19845766)
1. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
[TBL] [Abstract][Full Text] [Related]
2. Impact of plasma exchange on pharmacokinetic disposition of micafungin.
Konishi H; Fukushima K; Saotome T; Hamamoto T; Eguchi Y; Sudo M; Sumi M; Minouchi T; Iga I; Yamaji A
Ther Apher Dial; 2010 Jun; 14(3):358-63. PubMed ID: 20609192
[TBL] [Abstract][Full Text] [Related]
3. Effect of blood decrease on micafungin disposition in rats.
Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Yamaji A
Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):35-9. PubMed ID: 21350921
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants.
Kawada M; Fukuoka N; Kondo M; Okazaki K; Kusaka T; Kawada K; Itoh S
Pediatr Infect Dis J; 2009 Sep; 28(9):840-2. PubMed ID: 19636279
[TBL] [Abstract][Full Text] [Related]
5. Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats.
Abe F; Ueyama J; Kimata A; Kato M; Hayashi T; Nadai M; Saito H; Takeyama N; Noguchi H; Hasegawa T
Life Sci; 2008 Aug; 83(7-8):229-35. PubMed ID: 18638490
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of micafungin in patients undergoing allogeneic hematopoietic stem cell transplantation.
Oshima K; Kanda Y; Kako S; Ohno K; Kishino S; Kurokawa M
Transpl Infect Dis; 2013 Jun; 15(3):323-7. PubMed ID: 23578224
[TBL] [Abstract][Full Text] [Related]
7. The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction.
Muraki Y; Iwamoto T; Kagawa Y; Sakurai H; Usui M; Isaji S; Uemoto S; Okuda M
Biol Pharm Bull; 2009 Apr; 32(4):750-4. PubMed ID: 19336919
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of micafungin in pediatric patients with invasive candidiasis and candidemia.
Undre NA; Stevenson P; Freire A; Arrieta A
Pediatr Infect Dis J; 2012 Jun; 31(6):630-2. PubMed ID: 22301478
[TBL] [Abstract][Full Text] [Related]
9. Hexobarbital pharmacokinetics in rats after ligation of the common bile duct.
Drew R; Priestly BG; O'Reilly WJ
J Pharmacol Exp Ther; 1977 Jun; 201(3):534-40. PubMed ID: 864592
[TBL] [Abstract][Full Text] [Related]
10. Effect of liver and kidney function on migafungin disposition in patients with hematologic malignancies.
Nakagawa Y; Ichii Y; Saeki Y; Kodama M; Kishino S; Suzuki K
Eur J Drug Metab Pharmacokinet; 2008; 33(3):191-8. PubMed ID: 19007046
[TBL] [Abstract][Full Text] [Related]
11. Distribution of micafungin in the tissue fluids of patients with invasive fungal infections.
Yamada N; Kumada K; Kishino S; Mochizuki N; Ohno K; Ogura S
J Infect Chemother; 2011 Oct; 17(5):731-4. PubMed ID: 21537970
[TBL] [Abstract][Full Text] [Related]
12. Bronchopulmonary disposition of micafungin in healthy adult volunteers.
Nicasio AM; Tessier PR; Nicolau DP; Knauft RF; Russomanno J; Shore E; Kuti JL
Antimicrob Agents Chemother; 2009 Mar; 53(3):1218-20. PubMed ID: 19114675
[TBL] [Abstract][Full Text] [Related]
13. Recommendation to Exclude Bile-Duct-Cannulated Rats with Hyperbilirubinemia for Proper Conduct of Biliary Drug Excretion Studies.
Kato K; Hasegawa Y; Iwata K; Ichikawa T; Yahara T; Tsuji S; Sugiura M; Yamaguchi J
Drug Metab Dispos; 2016 Aug; 44(8):1180-3. PubMed ID: 27208382
[TBL] [Abstract][Full Text] [Related]
14. Micafungin concentrations in the plasma and burn eschar of severely burned patients.
Sasaki J; Yamanouchi S; Kudo D; Endo T; Nomura R; Takuma K; Kushimoto S; Shinozawa Y; Kishino S; Hori S; Aikawa N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1113-5. PubMed ID: 22083486
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of micafungin in neonates and young infants.
Hope WW; Smith PB; Arrieta A; Buell DN; Roy M; Kaibara A; Walsh TJ; Cohen-Wolkowiez M; Benjamin DK
Antimicrob Agents Chemother; 2010 Jun; 54(6):2633-7. PubMed ID: 20308367
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein function and expression during obstructive cholestasis in rats.
Micuda S; Brcakova E; Fuksa L; Cermanova J; Osterreicher J; Hroch M; Mokry J; Pejchal J; Martinkova J; Staud F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):404-12. PubMed ID: 18403942
[TBL] [Abstract][Full Text] [Related]
17. Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.
Vossen MG; Knafl D; Haidinger M; Lemmerer R; Unger M; Pferschy S; Lamm W; Maier-Salamon A; Jäger W; Thalhammer F
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584142
[TBL] [Abstract][Full Text] [Related]
18. In vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats.
Yanni SB; Augustijns PF; Benjamin DK; Brouwer KL; Thakker DR; Annaert PP
Drug Metab Dispos; 2010 Oct; 38(10):1848-56. PubMed ID: 20606004
[TBL] [Abstract][Full Text] [Related]
19. Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding.
Yanni SB; Smith PB; Benjamin DK; Augustijns PF; Thakker DR; Annaert PP
Biopharm Drug Dispos; 2011 May; 32(4):222-32. PubMed ID: 21449041
[TBL] [Abstract][Full Text] [Related]
20. Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Yoshikawa K; Nakazawa Y; Katsuyama Y; Hirabayashi K; Saito S; Shigemura T; Tanaka M; Yanagisawa R; Sakashita K; Koike K
Infection; 2014 Aug; 42(4):639-47. PubMed ID: 24567233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
